US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,389.24

+14.771.07%

Number of Gainers:10

Number of Losers:8

Number of Flat:1

PE:- -

High:1,392.07

Open:1,378.91

Low:1,378.91

Close:1,374.47

Loading ...

Kenvue Inc. Unveils Groundbreaking Clinical Studies on Oral and Skin Health, Highlighting Innovative Solutions for Diabetes Patients and Newborn Care

Pfizer’s Phase 1 Study on PF-07941944: Key Insights for Investors

BioNTech’s New Clinical Trial: A Potential Game-Changer in Cancer Treatment?

AstraZeneca, Daiichi Sankyo Win FDA Breakthrough Therapy Designation for Breast Cancer Drug

MT Newswires Live

Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors

BRIEF-FDA Announces Discontinuation Of Manufacture Of Some Pfizer's Pemetrexed Ditromethamine, Injection

Johnson & Johnson : UBS Raises Target Price to $190 From $180

THOMSON REUTERS

FDA: Discontinuation of Manufacture of Pfizer's Pemetrexed Ditromethamine, Injection, 100 Mg, 500 Mg Single Dose Vial- Website

THOMSON REUTERS

Abbott Laboratories Shares Down 5.6% After Q3 Forecast Below Estimates

THOMSON REUTERS

Tevogen Bio Expands with New Cell Therapy Manufacturing Facility in New Jersey

Abbott Exec Says $200 Million Tariff Impact Is Down From From Previous Estimates - Conf Call

THOMSON REUTERS

Abbott Exec Says Expect Annual Tariff Impact Just Under $200 Million - Conf Call

THOMSON REUTERS

Abbott Exec Says Co Expects Headwind of Around $700 Million on 2025 Sales Growth in Diagnostics - Conf Call

THOMSON REUTERS

Abbott down 5% at $125.40 after Q2 results, narrowed FY25 outlook

BioNTech SE Announces Resignation of Chief Strategy Officer Ryan Richardson Effective September 2025

Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors

Johnson & Johnson's TAR-200 Receives U.S. FDA Priority Review for High-Risk Bladder Cancer Treatment

Johnson & Johnson Receives U.S. FDA Priority Review for Tar-200 Nda in High-Risk Non-Muscle Invasive Bladder Cancer

THOMSON REUTERS

Moderna (MRNA) Receives a Sell from J.P. Morgan

BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1389.2404,"timestamp":1752849419501,"preClose":1374.4666,"halted":0,"volume":23464058,"delay":0,"changeRate":0.010749,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":14.773804,"latestTime":"07-18 10:36:59 EDT","open":1378.9058,"high":1392.0709,"low":1378.9058,"amount":1670365167.376555,"amplitude":0.009578,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1752868800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.73069,"peRate":21.631713,"turnoverRate":0.001533,"increases":10,"decrements":8,"flats":1,"marketCap":1145737402458.25,"floatMarketCap":1124958480796},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1392.0709,"amplitude":0.009578,"preClose":1374.4666,"low":1378.9058,"pbRate":"3.73069","latestPrice":1389.2404,"volume":23464068,"delay":0,"open":1378.9058,"prevYearClose":1274.8187,"prevWeekClose":1397.679,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1397.679,"twentyDayClose":1359.4229,"sixtyDayClose":1350.4775,"secType":"PLATE","market":"US","turnoverRate":0.001533,"peRate":21.631713,"marketCap":1145737402458.25,"floatMarketCap":1124958480796,"timestamp":1752849419641,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":10,"down":8,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552143975","title":"Kenvue Inc. Unveils Groundbreaking Clinical Studies on Oral and Skin Health, Highlighting Innovative Solutions for Diabetes Patients and Newborn Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2552143975","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552143975?lang=en_us&edition=fundamental","pubTime":"2025-07-18 03:47","pubTimestamp":1752781675,"startTime":"0","endTime":"0","summary":"Kenvue Inc. Unveils Groundbreaking Clinical Studies on Oral and Skin Health, Highlighting Innovative Solutions for Diabetes Patients and Newborn Care. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kenvue Inc. published the original content used to generate this news brief on July 17, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL3rWmdn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU2133065610.SGD","LU1074936037.SGD","SG9999001440.SGD","LU2592432038.USD","IE00B19Z3B42.SGD","IE00B2B36J28.USD","LU2430703251.USD","LU1066053197.SGD","LU2505996509.AUD","LU1066051498.USD","LU1894683348.USD","BK4007","LU1244550494.USD","LU1066051811.HKD","LU1267930573.SGD","LU0889566641.SGD","LU1221951129.SGD","BK4568","LU1914381329.SGD","IE00B7SZLL34.SGD","LU0114720955.EUR","LU1929549753.HKD","LU1267930813.SGD","LU0029864427.USD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0985320562.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","LU0122379950.USD","LU0058720904.USD","LU1732799900.SGD","SG9999002224.SGD","IE0009355771.USD","IE00BVYPNW00.USD","LU1732800096.USD","LU0466842654.USD","IE00BSNM7G36.USD","LU0795875169.SGD","LU1261432733.SGD","KVUE","LU1061106388.HKD","JNJ","LU0708994859.HKD","BK4534","LU0320765646.SGD","LU1032466523.USD","BK4581","BK4183"],"gpt_icon":0},{"id":"2552433889","title":"Pfizer’s Phase 1 Study on PF-07941944: Key Insights for Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2552433889","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552433889?lang=en_us&edition=fundamental","pubTime":"2025-07-18 00:19","pubTimestamp":1752769149,"startTime":"0","endTime":"0","summary":"Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. recently completed a Phase 1 clinical study titled A Multipart...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pfizers-phase-1-study-on-pf-07941944-key-insights-for-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pfizers-phase-1-study-on-pf-07941944-key-insights-for-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1066051498.USD","LU0456855351.SGD","BK4550","IE00BBT3K403.USD","SG9999003800.SGD","IE00BLSP4452.SGD","LU0225771236.USD","LU1023059063.AUD","BK4533","LU0321505439.SGD","BK4534","LU1883839398.USD","IE00BLSP4239.USD","LU0306807586.USD","SG9999011175.SGD","LU0289739699.SGD","LU0058720904.USD","BK4581","IE0002270589.USD","LU1066053197.SGD","PFE","LU1894683348.USD","SG9999002224.SGD","BK4592","BK4007","LU0234572021.USD","LU0321505868.SGD","BK4211","SG9999013999.USD","IE00B19Z3B42.SGD","ISBC","SG9999002232.USD","SG9999001176.SGD","BK4599","LU1057294990.SGD","LU0306806265.USD","BK4585","LU0122379950.USD","LU0225284248.USD","LU0868494617.USD","IE000M9KFDE8.USD","LU1894683264.USD","BK4568","SGXZ57979304.SGD","IE00B19Z3581.USD","SG9999001176.USD","BK4588","LU0985481810.HKD","LU0170899867.USD"],"gpt_icon":0},{"id":"2552433815","title":"BioNTech’s New Clinical Trial: A Potential Game-Changer in Cancer Treatment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2552433815","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552433815?lang=en_us&edition=fundamental","pubTime":"2025-07-18 00:16","pubTimestamp":1752768985,"startTime":"0","endTime":"0","summary":"Biontech SE (($CC:BNTX.CUR)), Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. BioNTech SE, in collaboratio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biontechs-new-clinical-trial-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biontechs-new-clinical-trial-a-potential-game-changer-in-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BNTX","BK4139","BK4535","BK4568","BK4548","BK4585","BK4551"],"gpt_icon":0},{"id":"2552433874","title":"AstraZeneca, Daiichi Sankyo Win FDA Breakthrough Therapy Designation for Breast Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2552433874","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552433874?lang=en_us&edition=fundamental","pubTime":"2025-07-18 00:12","pubTimestamp":1752768761,"startTime":"0","endTime":"0","summary":"AstraZeneca  and Daiichi Sankyo won breakthrough therapy designation from the US Food and Drug Administration for Enhertu, in combination with pertuzumab, as a treatment for adults with unresectable or metastatic HER2 positive breast cancer.The designation was based on a Phase 3 trial of 1,157 patients across five continents that evaluated Enhertu, alone or with pertuzumab, against the standard first-line regimen of taxane, trastuzumab, and pertuzumab, the companies said Thursday in a statement.Enhertu was discovered by Daiichi Sankyo and is being developed and commercialized jointly by the Tokyo-based company and AstraZeneca.Shares of AstraZeneca fell 1.2% in recent Thursday trading.Price: 69.24, Change: -0.84, Percent Change: -1.20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0889565916.HKD","BK4568","LU2462157665.USD","BK4585","AZN","LU1829250122.USD","LU2417539215.USD","LU2236285917.USD","BK4007","LU0320765992.SGD","LU2456880835.USD","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2552487792","title":"Eased Tariff Impact Fails To Lift Abbott As Outlook Cut Disappoints Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2552487792","media":"Benzinga","labels":["policyRegulatory","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552487792?lang=en_us&edition=fundamental","pubTime":"2025-07-17 22:48","pubTimestamp":1752763695,"startTime":"0","endTime":"0","summary":"Abbott posted Q2 revenue of $11.14 billion and EPS of $1.26, raised 2025 earnings guidance, and saw strong growth in diabetes and heart device sales.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/25/07/46470411/eased-tariff-impact-fails-to-lift-abbott-as-outlook-cut-disappoints-investors","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1721429402.USD","BK4592","BK4211","LU0868494617.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4533","LU2089984988.USD","BK4588","LU1061106388.HKD","LU2237957811.SGD","BK4082","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU1989763690.USD","BK4504","IE00B4R5TH58.HKD","ISBC","LU1691799644.USD","SGXZ23171101.USD","BK4585","BK4535","BNTX","LU0266013472.USD","SG9999002224.SGD","LU1721429741.USD","SG9999002232.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4548","LU2112291526.USD","LU1989763427.SGD","ABT","LU1057294990.SGD","LU0234572021.USD","BK4568","BK4566","BK4581","LU2133065610.SGD","BK4551","LU2237957902.USD","SG9999004303.SGD","IE0009355771.USD","LU1023059063.AUD","LU0170899867.USD"],"gpt_icon":0},{"id":"2552678487","title":"BRIEF-FDA Announces Discontinuation Of Manufacture Of Some Pfizer's Pemetrexed Ditromethamine, Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2552678487","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552678487?lang=en_us&edition=fundamental","pubTime":"2025-07-17 22:31","pubTimestamp":1752762669,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Announces Discontinuation Of Manufacture Of Some Pfizer's Pemetrexed Ditromethamine, InjectionJuly 17  - FDA:FDA: DISCONTINUATION OF MANUFACTURE OF PFIZER'S PEMETREXED DITROMETHAMINE, INJECTION, 100 MG, 500 MG SINGLE DOSE VIAL- WEBSITEFurther company coverage: PFE.N ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","IE00BLSP4239.USD","LU0234572021.USD","LU0225284248.USD","BK4585","SGXZ57979304.SGD","LU0306806265.USD","LU1894683264.USD","IE00BLSP4452.SGD","LU0456855351.SGD","LU1057294990.SGD","LU1883839398.USD","LU0321505439.SGD","LU0306807586.USD","SG9999002224.SGD","LU0122379950.USD","SG9999001176.SGD","BK4534","LU0225771236.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","SG9999011175.SGD","BK4592","BK4550","PFE","IE000M9KFDE8.USD","BK4007","LU0170899867.USD","LU0868494617.USD","LU1066051498.USD","SG9999002232.USD","LU1894683348.USD","LU0985481810.HKD","BK4568","BK4599","LU0058720904.USD","LU1023059063.AUD","SG9999003800.SGD","IE0002270589.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0321505868.SGD","SG9999013999.USD","LU1066053197.SGD","SG9999001176.USD","BK4533","BK4588"],"gpt_icon":0},{"id":"2552482269","title":"Johnson & Johnson : UBS Raises Target Price to $190 From $180","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482269","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552482269?lang=en_us&edition=fundamental","pubTime":"2025-07-17 22:10","pubTimestamp":1752761441,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nAZN470NGV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0234570918.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU0985320562.USD","LU1032466523.USD","LU1244550221.USD","BK4592","BK4533","LU1221951129.SGD","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0466842654.USD","IE00BJJMRZ35.SGD","IE00BN8TJ469.HKD","IE00B19Z3581.USD","SG9999001440.SGD","IE00BGHQF631.EUR","LU1061106388.HKD","LU0792757196.USD","IE0034235303.USD","LU2112291526.USD","LU2347655156.SGD","BK4568","LU0889566641.SGD","LU2592432038.USD","BK4504","IE00B3PB1722.GBP","LU0320765646.SGD","LU0098860793.USD","LU1267930813.SGD","LU2129689605.HKD","IE0002141913.USD","LU1585245621.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","BK4534","LU1894683264.USD","BK4559","LU2129689514.USD","LU1196500208.SGD","JNJ","LU1718418525.SGD","LU2430703095.HKD","IE00B42XCP33.USD","IE00BVYPNW00.USD","LU1674673428.USD","LU1244550577.SGD","LU1057294990.SGD","BK4588"],"gpt_icon":0},{"id":"2552482616","title":"FDA: Discontinuation of Manufacture of Pfizer's Pemetrexed Ditromethamine, Injection, 100 Mg, 500 Mg Single Dose Vial- Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2552482616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552482616?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:56","pubTimestamp":1752760563,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0306807586.USD","LU1894683348.USD","IE00BLSP4239.USD","IE0002270589.USD","SG9999001176.USD","BK4550","PFE","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU1066053197.SGD","LU0058720904.USD","LU0321505439.SGD","LU0225284248.USD","LU0225771236.USD","SG9999003800.SGD","LU1057294990.SGD","BK4534","LU1066051498.USD","IE00B19Z3581.USD","LU0868494617.USD","LU1894683264.USD","BK4533","IE00BLSP4452.SGD","BK4599","BK4568","BK4585","LU0321505868.SGD","BK4581","SG9999001176.SGD","SGXZ57979304.SGD","LU0306806265.USD","LU0170899867.USD","SG9999002232.USD","SG9999011175.SGD","BK4592","LU0234572021.USD","LU0456855351.SGD","LU0985481810.HKD","SG9999013999.USD","LU1023059063.AUD","IE00BBT3K403.USD","BK4007","BK4588","LU0289739699.SGD","LU0122379950.USD","LU1883839398.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2552973484","title":"Abbott Laboratories Shares Down 5.6% After Q3 Forecast Below Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2552973484","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552973484?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:34","pubTimestamp":1752759289,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE15N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU2133065610.SGD","BK4581","LU2237957902.USD","LU2237957811.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","ABT","LU2112291526.USD","BK4504","LU1914381329.SGD","LU1989763427.SGD","BK4566","BK4082","LU1691799644.USD","LU2089984988.USD","SGXZ23171101.USD","LU0266013472.USD","SG9999004303.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","IE00B2B36J28.USD","BK4588","LU1721429741.USD","LU1023059063.AUD","IE0009355771.USD","BK4585","LU0170899867.USD","SG9999002224.SGD","SG9999002232.USD","LU1989763690.USD","LU1721429402.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4533","BK4592","BK4568","IE0002141913.USD","LU1061106388.HKD","LU0234572021.USD"],"gpt_icon":0},{"id":"2552848654","title":"Tevogen Bio Expands with New Cell Therapy Manufacturing Facility in New Jersey","url":"https://stock-news.laohu8.com/highlight/detail?id=2552848654","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552848654?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:15","pubTimestamp":1752758129,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. has announced its plans to expand its operations by leasing a 17,428-square-foot facility in New Jersey, previously occupied by Pfizer and Cordis. This state-of-the-art facility will be dedicated to GMP cell therapy manufacturing, aligning with Tevogen's strategic objectives to accelerate clinical development while ensuring cost efficiency and scalability. The move is set to support the company's growing pipeline, powered by its proprietary AI-driven target discovery platform, PredicTcell. Tevogen anticipates beginning occupancy after finalizing the lease and obtaining necessary approvals, with the lease term expected to exceed five years. Dr. Ryan Saadi, CEO of Tevogen Bio, stated that this investment in infrastructure underscores the company's commitment to delivering innovative T cell therapies and efficiently scaling manufacturing as they move toward commercialization.Disclaimer: This news brief was created by Public Technologies  using generative artifici","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL1rR35q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4592","LU0234572021.USD","TVGN","LU0306807586.USD","LU0868494617.USD","BK4581","IE00BLSP4452.SGD","SG9999001176.USD","BK4585","SG9999003800.SGD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999011175.SGD","LU0122379950.USD","LU1066053197.SGD","IE00BGHQF748.EUR","LU0225771236.USD","LU0306806265.USD","BK4568","LU1894683348.USD","IE00BBT3K403.USD","BK4588","SG9999013999.USD","LU0058720904.USD","BK4139","LU1057294990.SGD","IE00B19Z3581.USD","SG9999001176.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4550","LU0225284248.USD","LU0321505439.SGD","LU1883839398.USD","BK4112","LU0321505868.SGD","SG9999002232.USD","LU0985481810.HKD","IE00B64PRP62.GBP","NDAQ","PFE","LU1894683264.USD","BK4599","LU0456855351.SGD","SGXZ57979304.SGD","LU0289739699.SGD","SG9999002224.SGD","LU2210150020.SGD","BK4007"],"gpt_icon":0},{"id":"2552840224","title":"Abbott Exec Says $200 Million Tariff Impact Is Down From From Previous Estimates - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2552840224","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552840224?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:09","pubTimestamp":1752757797,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE13X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4504","LU0122379950.USD","LU1057294990.SGD","SG9999002232.USD","IE0002141913.USD","SG9999002224.SGD","LU2468319806.SGD","LU1721429402.USD","BK4592","IE00B2B36J28.USD","SG9999004303.SGD","SGXZ23171101.USD","LU1989763690.USD","LU2237957902.USD","LU2133065610.SGD","BK4082","LU2112291526.USD","BK4588","LU1691799644.USD","LU0266013472.USD","BK4568","IE00BJT1NW94.SGD","LU0170899867.USD","BK4533","LU0234572021.USD","LU1023059063.AUD","LU1914381329.SGD","LU1721429741.USD","LU1989763427.SGD","IE00BFTCPJ56.SGD","BK4581","LU2089984988.USD","LU0868494617.USD","ABT","BK4585","LU2237957811.SGD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2552484393","title":"Abbott Exec Says Expect Annual Tariff Impact Just Under $200 Million - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2552484393","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552484393?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:09","pubTimestamp":1752757797,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE13X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","BK4585","LU2237957811.SGD","LU0266013472.USD","SG9999004303.SGD","LU1057294990.SGD","IE00BJJMRZ35.SGD","BK4568","IE0002141913.USD","IE00BJT1NW94.SGD","LU0170899867.USD","BK4592","LU2237957902.USD","LU0868494617.USD","LU1989763690.USD","LU1989763427.SGD","LU1061106388.HKD","LU0234572021.USD","SG9999002232.USD","BK4566","IE0009355771.USD","BK4504","LU1721429741.USD","BK4581","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4533","SG9999002224.SGD","SGXZ23171101.USD","BK4588","BK4082","LU0122379950.USD","LU2112291526.USD","LU2468319806.SGD","LU1914381329.SGD","LU2133065610.SGD","ABT","LU2089984988.USD","LU1721429402.USD","LU1691799644.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2552481753","title":"Abbott Exec Says Co Expects Headwind of Around $700 Million on 2025 Sales Growth in Diagnostics - Conf Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2552481753","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552481753?lang=en_us&edition=fundamental","pubTime":"2025-07-17 21:09","pubTimestamp":1752757797,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nFWN3TE13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2237957902.USD","IE0009355771.USD","LU1721429741.USD","LU2468319806.SGD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2237957811.SGD","LU0170899867.USD","LU2089984988.USD","BK4082","LU1989763690.USD","LU1914381329.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0122379950.USD","LU1061106388.HKD","BK4585","BK4581","LU0868494617.USD","LU0266013472.USD","LU1023059063.AUD","SG9999004303.SGD","LU0234572021.USD","LU1989763427.SGD","BK4592","LU2133065610.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","BK4533","LU1691799644.USD","SG9999002224.SGD","BK4568","IE00B4R5TH58.HKD","BK4566","ABT","BK4588","LU1721429402.USD","SGXZ23171101.USD","BK4504","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2552390481","title":"Abbott down 5% at $125.40 after Q2 results, narrowed FY25 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2552390481","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552390481?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755433,"startTime":"0","endTime":"0","summary":"Shares of Abbott (ABT) are down about 5% or $6.34 at $125.41, a three-month low, after reporting Q2 earnings and narrowing its guidance. Published ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abbott-down-5-at-125-40-after-q2-results-narrowed-fy25-outlook-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abbott-down-5-at-125-40-after-q2-results-narrowed-fy25-outlook-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","LU0868494617.USD","SG9999004303.SGD","LU1061106388.HKD","LU1721429741.USD","LU1989763427.SGD","LU1023059063.AUD","LU1989763690.USD","LU1721429402.USD","BK4588","IE00BFTCPJ56.SGD","LU0234572021.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","BK4504","SG9999002232.USD","BK4566","LU2133065610.SGD","LU2237957811.SGD","BK4592","BK4568","IE00BJJMRZ35.SGD","IE0002141913.USD","BK4581","SGXZ23171101.USD","BK4533","LU1691799644.USD","LU0266013472.USD","LU2112291526.USD","LU1914381329.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","SG9999002224.SGD","LU1057294990.SGD","LU2089984988.USD","LU2237957902.USD","BK4082","ABT","LU0170899867.USD","BK4585"],"gpt_icon":0},{"id":"2552489746","title":"BioNTech SE Announces Resignation of Chief Strategy Officer Ryan Richardson Effective September 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489746","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489746?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:30","pubTimestamp":1752755424,"startTime":"0","endTime":"0","summary":"BioNTech SE has announced that Ryan Richardson will step down from his roles as Chief Strategy Officer and Board Member, effective September 30, 2025. The company is in the process of transferring his responsibilities to other board members to ensure a smooth transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via GlobeNewswire  on July 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL1Ylhcg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","BK4535","BK4548","BNTX","LU2210150020.SGD","BK4568","IE00BGHQF748.EUR","LU2095319765.USD","BK4551","IE00B64PRP62.GBP","IE00BKPKM429.USD","IE00B3QW5Z07.USD","NDAQ","BK4588","LU2210149790.SGD","BK4139"],"gpt_icon":0},{"id":"2552489414","title":"Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489414","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489414?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:15","pubTimestamp":1752754500,"startTime":"0","endTime":"0","summary":"Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate g","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/17/3117185/0/en/Royalty-Pharma-Appoints-Carole-Ho-and-Elizabeth-Weatherman-to-the-Company-s-Board-of-Directors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4452.SGD","LU0985481810.HKD","SG9999013999.USD","LU1894683348.USD","LU1883839398.USD","LU1894683264.USD","BK4592","SG9999002232.USD","SG9999001176.SGD","SG9999011175.SGD","PFE","LU0234572021.USD","SG9999002224.SGD","BK4534","LU1057294990.SGD","IE0002270589.USD","LU1066051498.USD","SG9999001176.USD","LU0058720904.USD","LU0122379950.USD","SGXZ57979304.SGD","LU0456855351.SGD","LU0321505439.SGD","LU0321505868.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","BK4581","IE00B19Z3B42.SGD","LU0225771236.USD","BK4533","LU1066053197.SGD","IE00BLSP4239.USD","BK4550","BK4585","SG9999003800.SGD","LU0225284248.USD","LU0306807586.USD","LU0170899867.USD","IE00BBT3K403.USD","LU0289739699.SGD","LU1023059063.AUD","BK4588","BK4007","BK4599","BK4568","LU0868494617.USD","LU0306806265.USD"],"gpt_icon":0},{"id":"2552489398","title":"Johnson & Johnson's TAR-200 Receives U.S. FDA Priority Review for High-Risk Bladder Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489398","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489398?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:01","pubTimestamp":1752753671,"startTime":"0","endTime":"0","summary":"Johnson & Johnson has announced that the U.S. Food and Drug Administration  has granted Priority Review to their New Drug Application  for TAR-200, an innovative intravesical gemcitabine releasing system designed for the treatment of high-risk non-muscle invasive bladder cancer  that is unresponsive to Bacillus Calmette-Guérin  therapy. The NDA is supported by promising results from the Phase 2b SunRISe-1 study, which showed an 82.4% complete response rate, with more than half of the patients remaining cancer-free for at least a year. TAR-200 represents a significant advancement in drug delivery for bladder cancer, being the first intravesical drug releasing system to provide sustained treatment directly into the bladder. This regulatory milestone highlights Johnson & Johnson's commitment to transforming treatment options for bladder cancer, offering new hope for patients with limited alternatives.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nNDL1vdDCs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B1BXHZ80.USD","IE00B4R5TH58.HKD","IE00BGHQF631.EUR","BK4568","SG9999001440.SGD","LU0882574055.USD","LU1221951129.SGD","BK4533","LU1674673428.USD","LU1280957306.USD","LU1221951046.USD","LU1162221912.USD","LU1732799900.SGD","LU0640476718.USD","LU0345769128.USD","SG9999002232.USD","LU2468319806.SGD","IE0002141913.USD","LU2129689431.USD","BK4550","LU1914381329.SGD","IE0009355771.USD","IE00B2B36J28.USD","IE000M9KFDE8.USD","LU2129689514.USD","IE00BFTCPJ56.SGD","LU0098860793.USD","LU0792757196.USD","LU1059921491.USD","LU1778281490.HKD","LU1023059063.AUD","LU1261432733.SGD","BK4532","JNJ","LU1894683264.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","LU2430703251.USD","LU1066051225.USD","LU1732800096.USD","BK4504","IE00BLSP4452.SGD","LU0345770993.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU0345769631.USD","LU2089984988.USD","IE00B7SZLL34.SGD","LU1935042991.SGD","IE00BVYPNW00.USD"],"gpt_icon":0},{"id":"2552017486","title":"Johnson & Johnson Receives U.S. FDA Priority Review for Tar-200 Nda in High-Risk Non-Muscle Invasive Bladder Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2552017486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552017486?lang=en_us&edition=fundamental","pubTime":"2025-07-17 20:00","pubTimestamp":1752753606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nTUA5XDD3D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1066051498.USD","LU0289739699.SGD","IE000M9KFDE8.USD","BK4592","LU1267930813.SGD","LU1674673691.USD","IE0002270589.USD","LU2089984988.USD","LU2505996681.GBP","LU1244550577.SGD","LU1244550221.USD","LU0792757196.USD","IE0002141913.USD","BK4568","IE00B42XCP33.USD","IE00BSNM7G36.USD","LU1059921491.USD","LU1674673428.USD","LU2133065610.SGD","IE00BFXG1179.USD","LU1718418525.SGD","LU0985320562.USD","LU0882574055.USD","LU1430594728.SGD","LU1032955483.USD","BK4550","IE00B19Z3B42.SGD","LU0203345920.USD","LU1061106388.HKD","LU1066053197.SGD","LU2129689605.HKD","LU1057294990.SGD","LU1280957306.USD","LU1162221912.USD","LU0058720904.USD","IE00B19Z3581.USD","IE00B3T34201.USD","LU1221951129.SGD","JNJ","LU0122379950.USD","LU1244550494.USD","LU1506573853.SGD","SG9999002232.USD","IE00BGHQF631.EUR","LU0098860793.USD","IE00BVYPNV92.GBP","BK4588","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1935042991.SGD"],"gpt_icon":0},{"id":"2552489814","title":"Moderna (MRNA) Receives a Sell from J.P. Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2552489814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552489814?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:57","pubTimestamp":1752753424,"startTime":"0","endTime":"0","summary":"In a report released today, Jessica Fye from J.P. Morgan maintained a Sell rating on Moderna, with a price target of $26.00. The company’s shares c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/moderna-mrna-receives-a-sell-from-j-p-morgan-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","LU1162221912.USD","LU0106831901.USD","LU2347655156.SGD","LU0795875086.SGD","LU1989772840.SGD","LU0912757837.SGD","LU1720051017.SGD","LU0971096721.USD","LU2089284900.SGD","LU1668664300.SGD","LU0106261372.USD","LU0795875169.SGD","BK4139","BK4568","LU0006306889.USD","LU0225283273.USD","LU1732799900.SGD","BK4533","BK4548","BK4532","LU0158827948.USD","LU1720051108.HKD","LU1989772923.USD","LU2357305700.SGD","BK4534","BK4501","LU2089283258.USD","BK4127","LU0158827781.USD","LU0267386448.USD","BK4585","LU0098860793.USD","LU2023251221.USD","BK4516","LU2028103732.USD","LU0314104364.USD","IE00BKVL7J92.USD","LU1732800096.USD","LU2133065610.SGD","LU2271345857.HKD","MRNA","LU1074936037.SGD","LU1548497426.USD","LU2111349929.HKD","IE00BZ1G4Q59.USD","LU1363072403.SGD","BK4581","BK4588","LU0320765646.SGD"],"gpt_icon":0},{"id":"2552486419","title":"BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2552486419","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552486419?lang=en_us&edition=fundamental","pubTime":"2025-07-17 19:41","pubTimestamp":1752752512,"startTime":"0","endTime":"0","summary":"BUZZ-Street View: Johnson & Johnson's strength in product pipeline to drive growth** Johnson & Johnson JNJ.N halved its expectations for costs this year related to new tariffs and raised full-year sal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250717:nL4N3TE0LO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0098860793.USD","LU2065731478.USD","IE00B7SZLL34.SGD","LU0345770308.USD","LU0792757196.USD","IE0002141913.USD","LU2602419157.SGD","BK4112","BK4598","LU0234570918.USD","LU1261432733.SGD","LU0289739699.SGD","LU1718418525.SGD","LU1196500208.SGD","LU1894683264.USD","LU1162221912.USD","BK4581","LU1280957306.USD","LU1732800096.USD","LU1032955483.USD","IE00B42XCP33.USD","IE00BN8TJ469.HKD","IE0009355771.USD","IE00BLSP4452.SGD","IE0034235303.USD","BK4007","LU1244550221.USD","LU1674673691.USD","MORN","LU0466842654.USD","IE00BDGV0183.EUR","LU1267930813.SGD","JNJ","BK4568","LU1894683348.USD","BK4550","LU1585245621.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","SG9999002224.SGD","LU2430703251.USD","SG9999002232.USD","LU0345770993.USD","SG9999001440.SGD","LU2347655156.SGD","LU1914381329.SGD","LU1059921491.USD","BK4504","BK4592","BK4534"],"gpt_icon":0}],"pageSize":20,"totalPage":12,"pageCount":2,"totalSize":234,"code":"91000000","status":"200"}]}}